Renal remission status and longterm renal survival in patients with Lupus Nephritis: A retrospective cohort analysis

Julie E. Davidson, Qinggong Fu, Beulah Ji, Sapna Rao, David Roth, Laurence S. Magder, Michelle Petri

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Objective. This observational study was a retrospective analysis of prospectively collected Hopkins Lupus Cohort data to compare longterm renal survival in patients with lupus nephritis (LN) who achieved complete (CR), partial (PR), or no remission following standard-of-care LN induction therapy. Methods. Eligible patients with biopsy-proven LN (revised American College of Rheumatology or Systemic Lupus Collaborating Clinics criteria) were identified and categorized into ordinal (CR, PR, or no remission) or binary (response or no response) renal remission categories at 24 months post-diagnosis [modified Aspreva Lupus Management Study (mALMS) and modified Belimumab International Lupus Nephritis Study (mBLISS-LN) criteria]. The primary endpoint was longterm renal survival [without endstage renal disease (ESRD) or death]. Results. In total, 176 patients met the inclusion criteria. At Month 24 postbiopsy, more patients met mALMS remission criteria (CR = 59.1%, PR = 30.1%) than mBLISS-LN criteria (CR = 40.9%, PR = 16.5%). During subsequent followup, 18 patients developed ESRD or died. Kaplan–Meier plots suggested patients with no remission at Month 24 were more likely than those with PR or CR to develop the outcome using either mALMS (p = 0.0038) and mBLISS-LN (p = 0.0097) criteria for remission. Based on Cox regression models adjusted for key confounders, those in CR according to the mBLISS-LN (HR 0.254, 95% CI 0.082–0.787; p = 0.0176) and mALMS criteria (HR 0.228, 95% CI 0.063–0.828; p = 0.0246) were significantly less likely to experience ESRD/mortality than those not in remission. Conclusion. Renal remission status at 24 months following LN diagnosis is a significant predictor of longterm renal survival, and a clinically relevant endpoint.

Original languageEnglish (US)
Pages (from-to)671-677
Number of pages7
JournalJournal of Rheumatology
Issue number5
StatePublished - May 1 2018


  • Cohort Studies
  • Endstage Renal Disease
  • Lupus Nephritis
  • Mortality
  • Remission Induction
  • Survival

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Renal remission status and longterm renal survival in patients with Lupus Nephritis: A retrospective cohort analysis'. Together they form a unique fingerprint.

Cite this